We provide you with 20 years of free, institutional-grade data for TLSA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TLSA. Explore the full financial landscape of TLSA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Tiziana Life Sciences(NASDAQ:TLSA) 
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclona...
Website: http://www.tizianalifesciences.com
Founded: 1998
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about TLSA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.